BATE KENNETH
Insider CIK 1210238 · BMRN Director · MDGL Director · AVEO Director · VNDA Director · CATB Director · GNCA Director · EPZM Director · CBST Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| ATXS Astria Therapeutics, Inc. | D To issuer deriv | 2026-01-23 | 2026-01-23 | 14,100 | — | $0 | 0 | SEC↗ |
| ATXS Astria Therapeutics, Inc. | D To issuer deriv | 2026-01-23 | 2026-01-23 | 26,550 | — | $0 | 0 | SEC↗ |
| ATXS Astria Therapeutics, Inc. | D To issuer deriv | 2026-01-23 | 2026-01-23 | 16,666 | — | $0 | 0 | SEC↗ |
| ATXS Astria Therapeutics, Inc. | D To issuer deriv | 2026-01-23 | 2026-01-23 | 14,100 | — | $0 | 0 | SEC↗ |
| ATXS Astria Therapeutics, Inc. | D To issuer deriv | 2026-01-23 | 2026-01-23 | 8,333 | — | $0 | 0 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | M Exercise deriv | 2025-11-05 | 2025-11-07 | 10,000 | — | $0 | 0 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | M Exercise deriv | 2025-11-05 | 2025-11-07 | 5,470 | — | $0 | 0 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | M Exercise deriv | 2025-11-05 | 2025-11-07 | 1,105 | — | $0 | 0 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | S Sale | 2025-11-05 | 2025-11-07 | 1,931 | $484.78 | $936.1K | 8,896 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | S Sale | 2025-11-05 | 2025-11-07 | 2,069 | $483.41 | $1.00M | 10,827 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | S Sale | 2025-11-05 | 2025-11-07 | 1,284 | $482.41 | $619.4K | 12,896 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | S Sale | 2025-11-05 | 2025-11-07 | 3,259 | $481.13 | $1.57M | 14,180 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | M Exercise | 2025-11-05 | 2025-11-07 | 1,105 | $280.04 | $309.4K | 19,202 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | S Sale | 2025-11-05 | 2025-11-07 | 1,008 | $485.54 | $489.4K | 7,888 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | S Sale | 2025-11-05 | 2025-11-07 | 827 | $486.73 | $402.5K | 7,061 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | S Sale | 2025-11-05 | 2025-11-07 | 2,775 | $487.49 | $1.35M | 4,286 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | S Sale | 2025-11-05 | 2025-11-07 | 696 | $489.09 | $340.4K | 3,590 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | S Sale | 2025-11-05 | 2025-11-07 | 933 | $489.95 | $457.1K | 2,657 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | S Sale | 2025-11-05 | 2025-11-07 | 30 | $490.98 | $14.7K | 2,627 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | S Sale | 2025-11-05 | 2025-11-07 | 1,763 | $480.24 | $846.7K | 17,439 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | M Exercise | 2025-11-05 | 2025-11-07 | 5,470 | $9.45 | $51.7K | 8,097 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | M Exercise | 2025-11-05 | 2025-11-07 | 10,000 | $303.79 | $3.04M | 18,097 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | M Exercise deriv | 2025-08-15 | 2025-08-15 | 10,000 | — | $0 | 0 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | S Sale | 2025-08-15 | 2025-08-15 | 1,104 | $367.63 | $405.9K | 3,523 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | S Sale | 2025-08-15 | 2025-08-15 | 600 | $366.14 | $219.7K | 4,627 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | S Sale | 2025-08-15 | 2025-08-15 | 2,567 | $365.33 | $937.8K | 5,227 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | S Sale | 2025-08-15 | 2025-08-15 | 2,516 | $364.24 | $916.4K | 7,794 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | S Sale | 2025-08-15 | 2025-08-15 | 2,317 | $363.41 | $842.0K | 10,310 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | M Exercise | 2025-08-15 | 2025-08-15 | 10,000 | $16.46 | $164.6K | 12,627 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | S Sale | 2025-08-15 | 2025-08-15 | 896 | $368.56 | $330.2K | 2,627 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | A Award deriv | 2025-06-20 | 2025-06-24 | 1,290 | — | $0 | 1,290 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | A Award | 2025-06-20 | 2025-06-24 | 715 | — | $0 | 2,627 | SEC↗ |
| ATXS Astria Therapeutics, Inc. | A Award deriv | 2025-06-11 | 2025-06-12 | 26,550 | — | $0 | 26,550 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | M Exercise deriv | 2025-02-27 | 2025-02-28 | 6,000 | — | $0 | 0 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | M Exercise deriv | 2025-02-27 | 2025-02-28 | 4,530 | — | $0 | 5,470 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | M Exercise deriv | 2025-02-27 | 2025-02-28 | 9,470 | — | $0 | 0 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | M Exercise | 2025-02-27 | 2025-02-28 | 6,000 | $111.06 | $666.4K | 7,912 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | M Exercise | 2025-02-27 | 2025-02-28 | 9,470 | $65.06 | $616.1K | 17,382 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | M Exercise | 2025-02-27 | 2025-02-28 | 4,530 | $9.45 | $42.8K | 21,912 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | S Sale | 2025-02-27 | 2025-02-28 | 100 | $351.01 | $35.1K | 21,812 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | S Sale | 2025-02-27 | 2025-02-28 | 238 | $353.83 | $84.2K | 21,074 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | S Sale | 2025-02-27 | 2025-02-28 | 8,545 | $355.08 | $3.03M | 12,529 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | S Sale | 2025-02-27 | 2025-02-28 | 2,791 | $356.51 | $995.0K | 9,738 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | S Sale | 2025-02-27 | 2025-02-28 | 2,038 | $357.27 | $728.1K | 7,700 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | S Sale | 2025-02-27 | 2025-02-28 | 3,548 | $358.33 | $1.27M | 4,152 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | S Sale | 2025-02-27 | 2025-02-28 | 2,024 | $359.21 | $727.0K | 2,128 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | S Sale | 2025-02-27 | 2025-02-28 | 216 | $360.07 | $77.8K | 1,912 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | S Sale | 2025-02-27 | 2025-02-28 | 500 | $351.99 | $176.0K | 21,312 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | A Award deriv | 2024-06-25 | 2024-06-27 | 1,105 | — | $0 | 1,105 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | A Award | 2024-06-25 | 2024-06-27 | 714 | — | $0 | 1,912 | SEC↗ |
| ATXS Astria Therapeutics, Inc. | A Award deriv | 2024-06-05 | 2024-06-06 | 14,100 | — | $0 | 14,100 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | M Exercise deriv | 2024-04-02 | 2024-04-03 | 11,212 | — | $0 | 0 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | S Sale | 2024-04-02 | 2024-04-03 | 7 | $249.05 | $1.7K | 1,198 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | S Sale | 2024-04-02 | 2024-04-03 | 193 | $248.49 | $48.0K | 1,205 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | S Sale | 2024-04-02 | 2024-04-03 | 100 | $246.88 | $24.7K | 1,398 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | S Sale | 2024-04-02 | 2024-04-03 | 567 | $246.20 | $139.6K | 1,498 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | S Sale | 2024-04-02 | 2024-04-03 | 2,080 | $244.97 | $509.5K | 2,065 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | S Sale | 2024-04-02 | 2024-04-03 | 7,048 | $244.27 | $1.72M | 4,145 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | S Sale | 2024-04-02 | 2024-04-03 | 1,217 | $243.28 | $296.1K | 11,193 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | M Exercise | 2024-04-02 | 2024-04-03 | 11,212 | $105.08 | $1.18M | 12,410 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | M Exercise deriv | 2024-04-01 | 2024-04-03 | 10,000 | — | $0 | 0 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | M Exercise deriv | 2024-04-01 | 2024-04-03 | 10,000 | — | $0 | 10,000 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | M Exercise deriv | 2024-04-01 | 2024-04-03 | 1,277 | — | $0 | 11,212 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | S Sale | 2024-04-01 | 2024-04-03 | 700 | $265.36 | $185.8K | 1,472 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | S Sale | 2024-04-01 | 2024-04-03 | 841 | $262.18 | $220.5K | 2,431 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | S Sale | 2024-04-01 | 2024-04-03 | 200 | $259.13 | $51.8K | 3,272 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | S Sale | 2024-04-01 | 2024-04-03 | 2,104 | $258.24 | $543.3K | 3,472 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | S Sale | 2024-04-01 | 2024-04-03 | 2,790 | $257.33 | $718.0K | 5,576 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | S Sale | 2024-04-01 | 2024-04-03 | 7,411 | $256.49 | $1.90M | 8,366 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | S Sale | 2024-04-01 | 2024-04-03 | 6,698 | $255.62 | $1.71M | 15,777 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | M Exercise | 2024-04-01 | 2024-04-03 | 1,277 | $105.08 | $134.2K | 22,475 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | M Exercise | 2024-04-01 | 2024-04-03 | 10,000 | $100.45 | $1.00M | 21,198 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | M Exercise | 2024-04-01 | 2024-04-03 | 10,000 | $9.45 | $94.5K | 11,198 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | S Sale | 2024-04-01 | 2024-04-03 | 274 | $266.91 | $73.1K | 1,198 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | S Sale | 2024-04-01 | 2024-04-03 | 143 | $263.08 | $37.6K | 2,288 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | S Sale | 2024-04-01 | 2024-04-03 | 116 | $264.73 | $30.7K | 2,172 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | A Award | 2023-06-15 | 2023-06-20 | 1,198 | — | $0 | 1,198 | SEC↗ |
| ATXS Astria Therapeutics, Inc. | A Award deriv | 2023-06-02 | 2023-06-06 | 14,100 | — | $0 | 14,100 | SEC↗ |
| AVEO AVEO PHARMACEUTICALS, INC. | D To issuer deriv | 2023-01-19 | 2023-01-19 | 6,402 | — | $0 | 0 | SEC↗ |
| AVEO AVEO PHARMACEUTICALS, INC. | D To issuer deriv | 2023-01-19 | 2023-01-19 | 2,000 | — | $0 | 0 | SEC↗ |
| AVEO AVEO PHARMACEUTICALS, INC. | D To issuer deriv | 2023-01-19 | 2023-01-19 | 2,515 | — | $0 | 0 | SEC↗ |
| AVEO AVEO PHARMACEUTICALS, INC. | D To issuer deriv | 2023-01-19 | 2023-01-19 | 7,785 | — | $0 | 0 | SEC↗ |
| AVEO AVEO PHARMACEUTICALS, INC. | D To issuer deriv | 2023-01-19 | 2023-01-19 | 4,000 | — | $0 | 0 | SEC↗ |
| AVEO AVEO PHARMACEUTICALS, INC. | D To issuer deriv | 2023-01-19 | 2023-01-19 | 4,000 | — | $0 | 0 | SEC↗ |
| AVEO AVEO PHARMACEUTICALS, INC. | D To issuer deriv | 2023-01-19 | 2023-01-19 | 4,000 | — | $0 | 0 | SEC↗ |
| AVEO AVEO PHARMACEUTICALS, INC. | D To issuer deriv | 2023-01-19 | 2023-01-19 | 12,500 | — | $0 | 0 | SEC↗ |
| AVEO AVEO PHARMACEUTICALS, INC. | D To issuer deriv | 2023-01-19 | 2023-01-19 | 22,500 | — | $0 | 0 | SEC↗ |
| AVEO AVEO PHARMACEUTICALS, INC. | D To issuer deriv | 2023-01-19 | 2023-01-19 | 1,250 | — | $0 | 0 | SEC↗ |
| AVEO AVEO PHARMACEUTICALS, INC. | D To issuer deriv | 2023-01-19 | 2023-01-19 | 1,250 | — | $0 | 0 | SEC↗ |
| AVEO AVEO PHARMACEUTICALS, INC. | D To issuer | 2023-01-19 | 2023-01-19 | 375 | $15.00 | $5.6K | 375 | SEC↗ |
| EPZM Epizyme, Inc. | D To issuer | 2022-08-12 | 2022-08-16 | 8,060 | — | $0 | 8,994 | SEC↗ |
| EPZM Epizyme, Inc. | D To issuer | 2022-08-12 | 2022-08-16 | 8,994 | — | $0 | 0 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | A Award deriv | 2022-06-16 | 2022-06-21 | 9,470 | — | $0 | 9,470 | SEC↗ |
| ATXS Astria Therapeutics, Inc. | A Award deriv | 2022-06-09 | 2022-06-09 | 8,333 | — | $0 | 8,333 | SEC↗ |
| ATXS Astria Therapeutics, Inc. | A Award deriv | 2022-06-09 | 2022-06-21 | 8,333 | — | $0 | 8,333 | SEC↗ |
| AVEO AVEO PHARMACEUTICALS, INC. | A Award deriv | 2022-06-07 | 2022-06-08 | 22,500 | — | $0 | 22,500 | SEC↗ |
| EPZM Epizyme, Inc. | A Award deriv | 2022-05-17 | 2022-05-19 | 41,006 | — | $0 | 41,006 | SEC↗ |
| EPZM Epizyme, Inc. | A Award | 2022-05-17 | 2022-05-19 | 8,994 | — | $0 | 17,054 | SEC↗ |
| GNCA GENOCEA BIOSCIENCES, INC. | A Award deriv | 2021-07-01 | 2021-07-02 | 15,000 | — | $0 | 15,000 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | A Award deriv | 2021-06-17 | 2021-06-21 | 12,489 | — | $0 | 12,489 | SEC↗ |
| EPZM Epizyme, Inc. | A Award deriv | 2021-06-11 | 2021-06-15 | 40,559 | — | $0 | 40,559 | SEC↗ |
| EPZM Epizyme, Inc. | A Award | 2021-06-11 | 2021-06-15 | 8,060 | — | $0 | 8,060 | SEC↗ |
| AVEO AVEO PHARMACEUTICALS, INC. | A Award deriv | 2021-06-09 | 2021-06-09 | 12,500 | — | $0 | 12,500 | SEC↗ |
| CATB CATABASIS PHARMACEUTICALS | A Award deriv | 2021-06-02 | 2021-06-02 | 100,000 | — | $0 | 100,000 | SEC↗ |
| GNCA GENOCEA BIOSCIENCES, INC. | A Award deriv | 2020-06-18 | 2020-06-19 | 15,000 | — | $0 | 15,000 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | A Award deriv | 2020-06-17 | 2020-06-18 | 6,000 | — | $0 | 6,000 | SEC↗ |
| CATB CATABASIS PHARMACEUTICALS | A Award deriv | 2020-06-11 | 2020-06-12 | 7,500 | — | $0 | 7,500 | SEC↗ |
| AVEO AVEO PHARMACEUTICALS, INC. | A Award deriv | 2020-06-10 | 2020-06-30 | 4,000 | — | $0 | 4,000 | SEC↗ |
| EPZM Epizyme, Inc. | A Award deriv | 2020-05-29 | 2020-06-02 | 14,013 | — | $0 | 14,013 | SEC↗ |
| GNCA GENOCEA BIOSCIENCES, INC. | A Award deriv | 2019-07-18 | 2019-07-19 | 5,625 | — | $0 | 5,625 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | A Award deriv | 2019-06-27 | 2019-07-01 | 10,000 | — | $0 | 10,000 | SEC↗ |
| AVEO AVEO PHARMACEUTICALS INC | A Award deriv | 2019-06-12 | 2019-06-13 | 40,000 | — | $0 | 40,000 | SEC↗ |
| CATB CATABASIS PHARMACEUTICALS | A Award deriv | 2019-06-04 | 2019-06-05 | 7,500 | — | $0 | 7,500 | SEC↗ |
| EPZM Epizyme, Inc. | A Award deriv | 2019-05-31 | 2019-06-07 | 17,633 | — | $0 | 17,633 | SEC↗ |
| GNCA GENOCEA BIOSCIENCES, INC. | A Award deriv | 2018-06-21 | 2018-06-25 | 45,000 | — | $0 | 45,000 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | A Award deriv | 2018-06-19 | 2018-06-21 | 10,000 | — | $0 | 10,000 | SEC↗ |
| AVEO AVEO PHARMACEUTICALS INC | A Award deriv | 2018-06-18 | 2018-06-19 | 40,000 | — | $0 | 40,000 | SEC↗ |
| CATB CATABASIS PHARMACEUTICALS | A Award deriv | 2018-06-07 | 2018-06-07 | 14,000 | — | $0 | 14,000 | SEC↗ |
| EPZM Epizyme, Inc. | A Award deriv | 2018-05-18 | 2018-05-31 | 12,500 | — | $0 | 12,500 | SEC↗ |
| CATB CATABASIS PHARMACEUTICALS | A Award deriv | 2017-07-27 | 2017-07-28 | 6,500 | — | $0 | 6,500 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | A Award deriv | 2017-06-29 | 2017-06-30 | 10,000 | — | $0 | 10,000 | SEC↗ |
| EPZM Epizyme, Inc. | A Award deriv | 2017-06-22 | 2017-06-26 | 12,500 | — | $0 | 12,500 | SEC↗ |
| AVEO AVEO PHARMACEUTICALS INC | A Award deriv | 2017-06-21 | 2017-06-23 | 57,857 | — | $0 | 57,857 | SEC↗ |
| AVEO AVEO PHARMACEUTICALS INC | A Award deriv | 2017-06-21 | 2017-06-23 | 20,000 | — | $0 | 20,000 | SEC↗ |
| VNDA Vanda Pharmaceuticals Inc. | A Award deriv | 2017-06-15 | 2017-06-19 | 10,000 | — | $0 | 10,000 | SEC↗ |
| VNDA Vanda Pharmaceuticals Inc. | A Award | 2017-06-15 | 2017-06-19 | 5,000 | — | $0 | 5,000 | SEC↗ |
| GNCA GENOCEA BIOSCIENCES, INC. | A Award deriv | 2017-06-13 | 2017-06-15 | 15,000 | $5.34 | $80.1K | 15,000 | SEC↗ |
| CATB CATABASIS PHARMACEUTICALS | A Award deriv | 2016-08-03 | 2016-08-05 | 6,500 | — | $0 | 6,500 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | A Award deriv | 2016-07-22 | 2016-10-24 | 20,000 | — | $0 | 20,000 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | A Award deriv | 2016-07-22 | 2016-11-04 | 20,000 | — | $0 | 20,000 | SEC↗ |
| VNDA Vanda Pharmaceuticals Inc. | A Award deriv | 2016-06-16 | 2016-06-17 | 15,000 | — | $0 | 15,000 | SEC↗ |
| GNCA GENOCEA BIOSCIENCES, INC. | A Award deriv | 2016-06-07 | 2016-06-09 | 15,000 | — | $0 | 15,000 | SEC↗ |
| AVEO AVEO PHARMACEUTICALS INC | A Award deriv | 2016-05-26 | 2016-05-31 | 20,000 | — | $0 | 20,000 | SEC↗ |
| AVEO AVEO PHARMACEUTICALS INC | A Award deriv | 2016-05-26 | 2016-05-31 | 44,021 | — | $0 | 44,021 | SEC↗ |
| EPZM Epizyme, Inc. | A Award deriv | 2016-05-19 | 2016-05-23 | 12,500 | — | $0 | 12,500 | SEC↗ |
| VNDA Vanda Pharmaceuticals Inc. | A Award deriv | 2015-12-17 | 2015-12-21 | 35,000 | — | $0 | 35,000 | SEC↗ |
| EPZM Epizyme, Inc. | A Award deriv | 2015-07-08 | 2015-07-10 | 7,333 | — | $0 | 7,333 | SEC↗ |
| CATB CATABASIS PHARMACEUTICALS | A Award deriv | 2015-06-30 | 2015-06-30 | 11,094 | — | $0 | 11,094 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | A Award deriv | 2015-06-10 | 2015-06-18 | 3,300 | — | $0 | 3,300 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | A Award | 2015-06-10 | 2015-06-18 | 1,100 | — | $0 | 11,875 | SEC↗ |
| AVEO AVEO PHARMACEUTICALS INC | A Award deriv | 2015-05-28 | 2015-06-01 | 20,000 | — | $0 | 20,000 | SEC↗ |
| AVEO AVEO PHARMACEUTICALS INC | A Award deriv | 2015-04-02 | 2015-04-06 | 25,155 | — | $0 | 25,155 | SEC↗ |
| GNCA GENOCEA BIOSCIENCES, INC. | A Award deriv | 2015-02-26 | 2015-03-02 | 5,042 | — | $0 | 5,042 | SEC↗ |
| CBST CUBIST PHARMACEUTICALS INC | D To issuer deriv | 2015-01-21 | 2015-01-21 | 22,500 | — | $0 | 0 | SEC↗ |
| CBST CUBIST PHARMACEUTICALS INC | D To issuer deriv | 2015-01-21 | 2015-01-21 | 20,000 | — | $0 | 0 | SEC↗ |
| CBST CUBIST PHARMACEUTICALS INC | D To issuer deriv | 2015-01-21 | 2015-01-21 | 22,500 | — | $0 | 0 | SEC↗ |
| CBST CUBIST PHARMACEUTICALS INC | D To issuer deriv | 2015-01-21 | 2015-01-21 | 2,137 | — | $0 | 0 | SEC↗ |
| CBST CUBIST PHARMACEUTICALS INC | D To issuer deriv | 2015-01-21 | 2015-01-21 | 7,856 | — | $0 | 0 | SEC↗ |
| CBST CUBIST PHARMACEUTICALS INC | D To issuer deriv | 2015-01-21 | 2015-01-21 | 12,895 | — | $0 | 0 | SEC↗ |
| CBST CUBIST PHARMACEUTICALS INC | D To issuer deriv | 2015-01-21 | 2015-01-21 | 14,430 | — | $0 | 0 | SEC↗ |
| CBST CUBIST PHARMACEUTICALS INC | D To issuer deriv | 2015-01-21 | 2015-01-21 | 15,786 | — | $0 | 0 | SEC↗ |
| CBST CUBIST PHARMACEUTICALS INC | D To issuer deriv | 2015-01-21 | 2015-01-21 | 22,025 | — | $0 | 0 | SEC↗ |
| CBST CUBIST PHARMACEUTICALS INC | D To issuer deriv | 2015-01-21 | 2015-01-21 | 25,332 | — | $0 | 0 | SEC↗ |
| CBST CUBIST PHARMACEUTICALS INC | J Other | 2015-01-21 | 2015-01-21 | 9,615 | $102.00 | $980.7K | 0 | SEC↗ |
| EPZM Epizyme, Inc. | A Award deriv | 2014-12-10 | 2014-12-12 | 17,666 | — | $0 | 17,666 | SEC↗ |
| GNCA GENOCEA BIOSCIENCES, INC. | A Award deriv | 2014-09-11 | 2014-09-15 | 10,084 | — | $0 | 10,084 | SEC↗ |
| AVEO AVEO PHARMACEUTICALS INC | A Award deriv | 2014-06-19 | 2014-06-23 | 12,500 | — | $0 | 12,500 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | A Award deriv | 2014-06-04 | 2014-06-06 | 6,600 | — | $0 | 6,600 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | A Award | 2014-06-04 | 2014-06-06 | 2,100 | — | $0 | 10,775 | SEC↗ |
| CBST CUBIST PHARMACEUTICALS INC | M Exercise deriv | 2014-06-03 | 2014-06-05 | 1,701 | — | $0 | 0 | SEC↗ |
| CBST CUBIST PHARMACEUTICALS INC | A Award deriv | 2014-06-03 | 2014-06-05 | 2,137 | — | $0 | 2,137 | SEC↗ |
| CBST CUBIST PHARMACEUTICALS INC | A Award deriv | 2014-06-03 | 2014-06-05 | 7,856 | — | $0 | 7,856 | SEC↗ |
| CBST CUBIST PHARMACEUTICALS INC | M Exercise | 2014-06-03 | 2014-06-05 | 1,701 | — | $0 | 9,615 | SEC↗ |
| CBST CUBIST PHARMACEUTICALS INC | M Exercise deriv | 2014-02-03 | 2014-02-04 | 6,250 | — | $0 | 20,000 | SEC↗ |
| CBST CUBIST PHARMACEUTICALS INC | S Sale | 2014-02-03 | 2014-02-04 | 1,000 | $72.83 | $72.8K | 7,914 | SEC↗ |
| CBST CUBIST PHARMACEUTICALS INC | S Sale | 2014-02-03 | 2014-02-04 | 5,250 | $72.02 | $378.1K | 8,914 | SEC↗ |
| CBST CUBIST PHARMACEUTICALS INC | M Exercise | 2014-02-03 | 2014-02-04 | 6,250 | $22.71 | $141.9K | 14,164 | SEC↗ |
| CBST CUBIST PHARMACEUTICALS INC | M Exercise deriv | 2014-01-09 | 2014-01-09 | 10,000 | — | $0 | 0 | SEC↗ |
| CBST CUBIST PHARMACEUTICALS INC | S Sale | 2014-01-09 | 2014-01-09 | 10,000 | $70.00 | $700.0K | 7,914 | SEC↗ |
| CBST CUBIST PHARMACEUTICALS INC | M Exercise | 2014-01-09 | 2014-01-09 | 10,000 | $9.56 | $95.6K | 17,914 | SEC↗ |
| CBST CUBIST PHARMACEUTICALS INC | M Exercise deriv | 2013-12-02 | 2013-12-03 | 12,500 | — | $0 | 0 | SEC↗ |
| CBST CUBIST PHARMACEUTICALS INC | S Sale | 2013-12-02 | 2013-12-03 | 2,206 | $68.10 | $150.2K | 7,914 | SEC↗ |
| CBST CUBIST PHARMACEUTICALS INC | M Exercise | 2013-12-02 | 2013-12-03 | 12,500 | $10.09 | $126.1K | 20,414 | SEC↗ |
| CBST CUBIST PHARMACEUTICALS INC | S Sale | 2013-12-02 | 2013-12-03 | 10,294 | $67.53 | $695.2K | 10,120 | SEC↗ |
| CBST CUBIST PHARMACEUTICALS INC | A Award deriv | 2013-06-12 | 2013-06-14 | 1,701 | — | $0 | 1,701 | SEC↗ |
| CBST CUBIST PHARMACEUTICALS INC | A Award deriv | 2013-06-12 | 2013-06-14 | 12,895 | — | $0 | 12,895 | SEC↗ |
| CBST CUBIST PHARMACEUTICALS INC | M Exercise deriv | 2013-06-06 | 2013-06-11 | 2,075 | — | $0 | 0 | SEC↗ |
| CBST CUBIST PHARMACEUTICALS INC | M Exercise | 2013-06-06 | 2013-06-11 | 2,075 | — | $0 | 7,914 | SEC↗ |
| CBST CUBIST PHARMACEUTICALS INC | M Exercise deriv | 2013-06-03 | 2013-06-03 | 2,500 | — | $0 | 0 | SEC↗ |
| CBST CUBIST PHARMACEUTICALS INC | S Sale | 2013-06-03 | 2013-06-03 | 2,500 | $54.95 | $137.4K | 5,839 | SEC↗ |
| CBST CUBIST PHARMACEUTICALS INC | M Exercise | 2013-06-03 | 2013-06-03 | 2,500 | $11.89 | $29.7K | 8,339 | SEC↗ |
| AVEO AVEO PHARMACEUTICALS INC | A Award deriv | 2013-05-29 | 2013-05-30 | 12,500 | — | $0 | 12,500 | SEC↗ |
| CBST CUBIST PHARMACEUTICALS INC | M Exercise deriv | 2013-05-15 | 2013-05-17 | 2,500 | — | $0 | 2,500 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | A Award deriv | 2013-05-15 | 2013-05-20 | 8,500 | — | $0 | 8,500 | SEC↗ |
| CBST CUBIST PHARMACEUTICALS INC | S Sale | 2013-05-15 | 2013-05-17 | 2,500 | $48.41 | $121.0K | 5,839 | SEC↗ |
| CBST CUBIST PHARMACEUTICALS INC | M Exercise | 2013-05-15 | 2013-05-17 | 2,500 | $11.89 | $29.7K | 8,339 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | A Award | 2013-05-15 | 2013-05-20 | 3,400 | — | $0 | 8,675 | SEC↗ |
| CBST CUBIST PHARMACEUTICALS INC | M Exercise deriv | 2013-03-06 | 2013-03-07 | 5,000 | — | $0 | 5,000 | SEC↗ |
| CBST CUBIST PHARMACEUTICALS INC | S Sale | 2013-03-06 | 2013-03-07 | 5,000 | $47.50 | $237.5K | 5,839 | SEC↗ |
| CBST CUBIST PHARMACEUTICALS INC | M Exercise | 2013-03-06 | 2013-03-07 | 5,000 | $11.89 | $59.5K | 10,839 | SEC↗ |
| CBST CUBIST PHARMACEUTICALS INC | A Award deriv | 2012-06-06 | 2012-06-11 | 14,430 | — | $0 | 14,430 | SEC↗ |
| CBST CUBIST PHARMACEUTICALS INC | A Award deriv | 2012-06-06 | 2012-06-11 | 2,075 | — | $0 | 2,075 | SEC↗ |
| AVEO AVEO PHARMACEUTICALS INC | A Award deriv | 2012-05-30 | 2012-06-05 | 12,500 | — | $0 | 12,500 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | A Award deriv | 2012-05-08 | 2012-05-10 | 8,500 | — | $0 | 49,750 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | A Award | 2012-05-08 | 2012-05-10 | 3,400 | — | $0 | 5,275 | SEC↗ |